Key terms
About BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BSX news
Yesterday
2:32pm ET
Boston Scientific recalls 1,594 Obsidio Embolic devices in U.S.
Apr 15
8:06am ET
Boston Scientific price target raised to $78 from $70 at RBC Capital
Apr 15
7:35am ET
Boston Scientific price target raised to $74 from $72 at BTIG
Apr 15
6:08am ET
Integer upgraded to Buy from Neutral at BofA
Apr 05
12:15am ET
Evercore ISI Keeps Their Buy Rating on Boston Scientific (BSX)
Apr 03
11:51am ET
Boston Scientific price target raised to $80 from $69 at Argus
Apr 03
5:51am ET
Boston Scientific price target raised to $79 from $71 at Citi
Mar 27
8:14am ET
Piper says competitive process could materialize for ShockWave
Mar 22
4:02pm ET
Axonics shareholders approve merger with Boston Scientific
Mar 22
7:06am ET
Piper Sandler Sticks to Their Buy Rating for Boston Scientific (BSX)
Mar 07
7:24am ET
Boston Scientific price target raised to $77 from $65 at TD Cowen
Mar 07
4:21am ET
Analysts Are Bullish on Top Healthcare Stocks: Viking Therapeutics (VKTX), Boston Scientific (BSX)
Mar 06
7:35am ET
Piper Sandler Keeps Their Buy Rating on Boston Scientific (BSX)
Mar 03
10:33am ET
Analysts Conflicted on These Healthcare Names: Boston Scientific (BSX), ANI Pharmaceuticals (ANIP) and Merck & Company (MRK)
Mar 01
6:57am ET
Boston Scientific receives FDA approval for Farapulse PFA System
Feb 29
6:30am ET
Boston Scientific (BSX) Receives a Buy from Wells Fargo
Feb 27
7:51am ET
Analysts Are Bullish on Top Healthcare Stocks: ANI Pharmaceuticals (ANIP), Boston Scientific (BSX)
Feb 06
5:38am ET
Boston Scientific’s Farapulse Poised for Growth on Positive Physician Sentiment and Anticipated Reimbursement Incentives
Feb 05
8:10am ET
Analysts Are Bullish on Top Healthcare Stocks: 4D Molecular Therapeutics (FDMT), Boston Scientific (BSX)
Feb 02
10:48am ET
Wells upgrades Edwards Lifesciences, says tricuspid opportunity underappreciated
Feb 01
8:10pm ET
Boston Scientific price target raised to $70 from $60 at Barclays
Feb 01
9:58am ET
Qualcomm downgraded, Cigna upgraded: Wall Street’s top analyst calls
Feb 01
8:49am ET
Boston Scientific price target raised to $63 from $55 at Deutsche Bank
Feb 01
8:25am ET
Boston Scientific price target raised to $73 from $70 at Truist
Feb 01
8:00am ET
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Insmed (INSM) and Amgen (AMGN)
Feb 01
7:54am ET
Boston Scientific price target raised to $81 from $77 at Canaccord
Feb 01
7:49am ET
Boston Scientific price target raised to $70 from $67 at RBC Capital
Feb 01
7:47am ET
Mizuho upgrades Boston Scientific to Buy on durable growth
Feb 01
7:43am ET
Boston Scientific upgraded to Buy from Neutral at Mizuho
Feb 01
7:11am ET
Analysts Are Bullish on Top Healthcare Stocks: Boston Scientific (BSX), Teladoc (TDOC)
Feb 01
6:50am ET
Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Humana (HUM) and Boston Scientific (BSX)
No recent press releases are available for BSX
BSX Financials
Key terms
Ad Feedback
BSX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BSX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
